Pan-cancer analysis of Arp2/3 complex subunits: focusing on ARPC1A’s role and validating the ARPC1A/c-Myc axis in non-small cell lung cancer
Our study offers novel insights into targeting Arp2/3 complex subunits as an anti-cancer strategy and underscores the potential of ARPC1A as a novel biomarker for tumor diagnosis, prognosis, and the prediction of immune therapy responses.
Authors
- Y. Q. Chen (ORCID: https://orcid.org/0009-0002-7350-7091)
- Lijuan Hu (ORCID: https://orcid.org/0000-0002-6889-1650)
- Chenkang Zhou (ORCID: https://orcid.org/0009-0001-9526-6105)
- Junjun Wang (ORCID: https://orcid.org/0000-0002-8066-4274)
- Yumin Wang (ORCID: https://orcid.org/0000-0001-7023-7159)
- Shuhui Chen (ORCID: https://orcid.org/0000-0002-6692-3217)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3389/fimmu.2024.1491910
- Citations
- 5
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 4.03